Musely Secures $360M Without Diluting Equity
Musely has raised over $360 million in non-dilutive capital, revolutionizing funding for DTC brands. Discover how this innovative financing model is reshaping the telemedicine landscape.
Innovative Funding for Telemedicine
Musely, a direct-to-consumer telemedicine platform, has successfully secured more than $360 million from General Catalyst’s Customer Value Fund (CVF) without giving up equity. This unique funding model allows companies with predictable revenue to borrow capital and repay it through a fixed percentage of their revenue, making it a compelling alternative to traditional loans.
Co-founder and CEO Jack Jia emphasized that Musely has been cash flow positive for years, which made him hesitant to dilute ownership through standard venture capital. However, after analyzing CVF's terms, he found them to be more favorable than traditional bank loans. This funding will enable Musely to enhance its sales and marketing efforts, crucial for acquiring new customers in a competitive market.
- •Key Highlights:
- •Musely has grown its revenue by 50% year-over-year.
- •The platform serves over 1.2 million patients.
- •CVF's portfolio includes notable companies like Grammarly and Lemonade.
With this strategic funding, Musely is poised to expand its reach and continue its mission of providing accessible prescription skincare solutions.